Epoetin theta

Key facts

Active substance
epoetin theta
Therapeutic area
Haematology-Hemostaseology
Decision number
P/57/2008
PIP number
Epoetin theta
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of anaemia
Route(s) of administration
  • Intravenous use
  • Subcutaneous use
Contact for public enquiries
Ratiopharm GmbH
E-mail: info@ratiopharm.de
Country: Germany
Phone: +49 73140202
Fax: +49 7314027832
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating